Getting started with PathoGenius®
PathoGenius® offers DNA guided, personalized medicine for wound care.
PathoGenius® offers specifically designed Rapid screening for ENT applications and comprehensive bacterial and fungal diagnostics.
PathoGenius® extends rapid screen molecular diagnostics for ENT and respiratory viruses.
PathoGenius® offers specifically designed Rapid screening for BV as well as comprehensive bacterial and fungal diagnostics persistent infections.
With molecular diagnostics offered by PathoGenius®, physicians are able to know exactly which micro-organisms are present in any given wound. Once the pathogenic organisms are identified, medications can be selected and ratios adjusted to specifically address the individual wound bed, thereby allowing for a precise treatment that ultimately expedites healing -- 2 to 5 times faster in most cases. These specifically developed treatments are often referred to as Personalized Medicine. Furthermore, most insurance companies cover our services.
The dramatic advantages PathoGenius® offers over traditional culture based analysis have been clearly cited in our published work. The following are some of the findings:
• 99% of chronic wounds are polymicrobial, with high abundance levels.
- This means that there are almost always many different organisms present in a wound contributing to the infected state of a wound bed. The challenge here is that many of these microorganisms are very different from each other, and require special attention.
• Less than 5% of known wound microbes can be grown using traditional culture techniques
- This means that the majority of the microbes (over 95%) contributing to the community of organisms within the biofilm allowing the wound to persist will NOT be detected using traditional culture techniques.
- The limitations of traditional culture techniques lead to increased treatment cost through longer treatment times, more invasive medical interventions, and a higher incidence of progressed complications.
- Most importantly, this leads to increased pain and suffering.
• PathoGenius® empowers the physician to treat the bioburden with DNA level certainty.
• The microbial Bioburden is a significant barrier for all chronic wounds, regardless of etiology
• As a universal barrier, we must make it a universal strategy to utilize molecular diagnostics to maximize healing outcomes.
• The microbial Bioburden is the only barrier to healing completely in the clinician’s control to manage. (Journal of Wound Care 2011; 20: 5, 232)
In a recent study of over 1400 wound patients, the healing rates for patients that received testing by PathoGenius® and followed the suggested treatment protocols were approximately 2 to 5 times faster! In science and medicine, there are of course no guarantees of success. However, success is dependent on the accuracy of testing information, and we can guarantee that there is no more accurate method of testing for microbial analysis than molecular DNA analysis.
JWoundCare 2011; 20:5, 232
Three groups of wound patients were monitored for 206 days: The Culture Systemic group followed traditional culture directed wound treatments. The DNA Dx/Systemic group followed traditional systemic treatments guided by molecular DNA analysis offered by PathoGenius®. The DNA Dx/Topical group of patients followed personalized topical/transdermal treatments directed by molecular DNA analysis offered by PathoGenius®.
A division of Southwest Regional PCR, LLC
Copyright © 2017. PathoGenius® Laboratories. All Rights Reserved.